Vanguard Personalized Indexing Management LLC Increases Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Vanguard Personalized Indexing Management LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.9% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 30,684 shares of the company’s stock after acquiring an additional 3,020 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in GE HealthCare Technologies were worth $2,391,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Capital Research Global Investors increased its stake in GE HealthCare Technologies by 5.2% during the first quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock worth $4,908,406,000 after acquiring an additional 2,647,204 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of GE HealthCare Technologies by 9.2% in the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after acquiring an additional 4,107,746 shares during the period. Hotchkis & Wiley Capital Management LLC grew its holdings in shares of GE HealthCare Technologies by 9.4% during the fourth quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock worth $426,186,000 after buying an additional 471,910 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of GE HealthCare Technologies by 41.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,875,589 shares of the company’s stock valued at $145,021,000 after acquiring an additional 550,612 shares in the last quarter. Finally, Perpetual Ltd purchased a new position in shares of GE HealthCare Technologies in the 1st quarter valued at about $96,135,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.27% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on GEHC shares. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a report on Wednesday. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 target price for the company. The Goldman Sachs Group started coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target for the company. Finally, Stifel Nicolaus started coverage on GE HealthCare Technologies in a research report on Tuesday, August 6th. They set a “buy” rating and a $100.00 price target for the company. Six investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average target price of $95.00.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $90.28 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The firm has a fifty day simple moving average of $83.86 and a 200 day simple moving average of $83.36. The company has a market capitalization of $41.21 billion, a PE ratio of 26.40, a P/E/G ratio of 3.26 and a beta of 1.17. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same period last year, the firm earned $0.92 earnings per share. The firm’s revenue was up .5% on a year-over-year basis. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $0.03 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.